Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Safety and Efficacy of Ruxolitinib for the Final Enrollment of JUMP: An Open-Label, Multicenter, Single-Arm, Expanded-Access Study in Patients with Myelofibrosis (N = 2233)

Lynda Foltz, MD FRCP, Giuseppe A. Palumbo, MD, Bruno Martino, MD, Francesca Palandri, MD PhD, Haifa Kathrin Al-Ali, MD, Anna Marina Liberati, MD, Philipp D. Le Coutre, MD, Alessandro M. Vannucchi, MD, Carmen Garcia-Hernandez, MD, Renato Tavares, MD, Martin Griesshammer, MD, Vikas Gupta, MD, Pia Raanani, MD, Pilar Giraldo, MD PhD, Catherine Bouard, Julian Perez Ronco, MD MBA, Sadhvi Khanna, MS, Andrey Zaritskey, MD

Blood (2016) 128 (22): 3107.

https://doi.org/10.1182/blood.V128.22.3107.3107

Published: 2016

Journal Articles

The Impact of Myeloproliferative Neoplasms (MPNs) on Patients' Quality of Life and Productivity: Results from the International MPN Landmark Survey

Claire N. Harrison, DM, FRCP, FRCPath, Steffen Koschmieder, MD, Lynda Foltz, MD FRCP, Paola Guglielmelli, MD, Tina Flindt, AAS, Michael Koehler, Dipl.-Psych., Dr. rer. MDc., Jonathan Mathias, BSc, Norio Komatsu, MD PhD, Robert N. Boothroyd, PharmD, Amber Spierer, MPH, Julian Perez Ronco, MD, Gavin Taylor-Stokes, MBA, John Waller, PhD, Ruben A. Mesa, MD

Blood (2016) 128 (22): 4267.

https://doi.org/10.1182/blood.V128.22.4267.4267

Published: 2016

Journal Articles

Safety and Efficacy of Ruxolitinib in an 1869-Patient Cohort of JUMP: An Open-Label, Multicenter, Single-Arm, Expanded-Access Study in Patients with Myelofibrosis

Renato Tavares, MD, Giuseppe A. Palumbo, MD, Philipp Le Coutre, MD, Francesca Palandri, MD PhD, Haifa Kathrin Al-Ali, MD, Bruno Martino, MD, Anna Marina Liberati, MD, Jose Grasa Ullrich, MD, Massimo Breccia, MD, David Brittain, MD, Lynda Foltz, MD FRCP, Martin Griesshammer, MD, Pia Raanani, MD, Vikas Gupta, MD FRCP, FRCPath, Pilar Giraldo, MD PhD, Jagannath Ghosh, Bayane Tannir, Julian Perez Ronco, MD MBA, Alessandro M. Vannucchi, MD

Blood (2015) 126 (23): 2799.

https://doi.org/10.1182/blood.V126.23.2799.2799

Published: 2015

Journal Articles

Safety and Efficacy of Ruxolitinib in an Open-Label, Multicenter, Single-Arm, Expanded-Access Study in Patients with Myelofibrosis (MF): An 1144-Patient Update

Bruno Martino, Philipp le Coutre, MD, Martin Griesshammer, MD, Thomas Illmer, MD, Rudolf Schlag, Cornelius F. Waller, MD, Anna Marina Liberati, Philippe Schafhausen, MD, Renato S Tavares, MD, Alessandro M. Vannucchi, MD, Pilar Giraldo, MD PhD, Lynda M Foltz, MD FRCP, Pia Raanani, MD, Vikas Gupta, MD FRCP, FRCPath, Bayane Tannir, Julian Perez Ronco, MD, Jaggannath Ghosh, Haifa Kathrin Al-Ali, MD

Blood (2014) 124 (21): 3197.

https://doi.org/10.1182/blood.V124.21.3197.3197

Published: 2014

Journal Articles

Safety and Efficacy of Ruxolitinib Retreatment after Treatment Interruption in Patients Enrolled in an Open-Label, Multicenter, Expanded-Access Study in Myelofibrosis

Vikas Gupta, MD FRCP, FRCPath, Renato S Tavares, MD, Martin Griesshammer, MD, Lynda M Foltz, MD FRCP, Pia Raanani, MD, Pilar Giraldo, Haifa Kathrin Al-Ali, MD, Bruno Martino, MD, Bayane Tannir, Julian Perez Ronco, MD, Jagannath Ghosh, Alessandro M. Vannucchi, MD

Blood (2014) 124 (21): 5567.

https://doi.org/10.1182/blood.V124.21.5567.5567

Published: 2014

Journal Articles

Real-World Assessment of Clinical Outcomes in Lower-Risk Myelofibrosis Patients Receiving Treatment with Ruxolitinib

Keith L Davis, MA, James A. Kaye, MD DrPH, Isabelle Cote, PhD, Haitao Gao, Julian Perez Ronco, MD, Raafat Seifeldin, Pharm D, MS, PhD, Estella Mendelson, BSRN, MBA

Blood (2014) 124 (21): 1857.

https://doi.org/10.1182/blood.V124.21.1857.1857

Published: 2014

Journal Articles

Safety and Efficacy of Ruxolitinib in Patients with Low Platelets Enrolled in a Phase 3b Expanded-Access Study in Myelofibrosis (MF)

Martin Griesshammer, MD, Alessandro M. Vannucchi, MD, Philipp le Coutre, MD, Renato S Tavares, MD, Haifa Kathrin Al-Ali, MD, Pia Raanani, MD, Vikas Gupta, MD FRCP, FRCPath, Lynda M Foltz, MD FRCP, Pilar Giraldo, Catherine Bouard, Julian Perez Ronco, MD MBA, Jagannath Ghosh, Bruno Martino, MD

Blood (2014) 124 (21): 1859.

https://doi.org/10.1182/blood.V124.21.1859.1859

Published: 2014

Journal Articles

Ruxolitinib Overcomes the Adverse Prognostic Effect of Anemia in Patients with Myelofibrosis (MF)

Haifa Kathrin Al-Ali, MD, Viktoriya Stalbovskaya, PhD, Prashanth Gopalakrishna, MBBS, MRCS, Julian Perez Ronco, MD MBA, Lynda M Foltz, MD FRCP

Blood (2014) 124 (21): 4583.

https://doi.org/10.1182/blood.V124.21.4583.4583

Published: 2014

NARROW

Safety and Efficacy of Ruxolitinib for the Final Enrollment of JUMP: An Open-Label, Multicenter, Single-Arm, Expanded-Access Study in Patients with Myelofibrosis (N = 2233)

The Impact of Myeloproliferative Neoplasms (MPNs) on Patients' Quality of Life and Productivity: Results from the International MPN Landmark Survey

Safety and Efficacy of Ruxolitinib in an 1869-Patient Cohort of JUMP: An Open-Label, Multicenter, Single-Arm, Expanded-Access Study in Patients with Myelofibrosis

Safety and Efficacy of Ruxolitinib in an Open-Label, Multicenter, Single-Arm, Expanded-Access Study in Patients with Myelofibrosis (MF): An 1144-Patient Update

Safety and Efficacy of Ruxolitinib Retreatment after Treatment Interruption in Patients Enrolled in an Open-Label, Multicenter, Expanded-Access Study in Myelofibrosis

Real-World Assessment of Clinical Outcomes in Lower-Risk Myelofibrosis Patients Receiving Treatment with Ruxolitinib

Safety and Efficacy of Ruxolitinib in Patients with Low Platelets Enrolled in a Phase 3b Expanded-Access Study in Myelofibrosis (MF)

Ruxolitinib Overcomes the Adverse Prognostic Effect of Anemia in Patients with Myelofibrosis (MF)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only